CBNGO00044: Focus on glycoprotein synthesis and function research 2855124-64-8

In the forefront of glycochemical biology and innovative drug research and development, glycosylation modification, as one of the most important post-translational modifications of proteins, profoundly affects the structure, stability, immunogenicity and function of proteins. The precise synthesis of glycoproteins with uniform structure and biological activity has always been a core challenge and technical bottleneck in this field. As a key intermediate, Glycan Oxazoline provides an efficient and specific chemoenzymatic synthesis solution to this challenge, and is increasingly becoming an indispensable tool molecule for glycoprotein research and therapeutic glycoprotein development.

Chemical Information

Chemical name: Glycosyloxazoline derivatives

Common name: CBNGO00044

Chemical formula: C26H44NO23P

Molecular weight: 769.60 g/mol

CAS number:

2855124

-64-8

Structural features

CBNGO00044 belongs to the Glycan Oxazoline class of compounds, and its structural design contains exquisite chemical and enzymatic principles:

Stable active intermediate: The oxazoline ring structure in the molecule is an efficient donor for glycosylation reactions catalyzed by glycosyltransferases (especially endoglycosidases and their mutants). The ring structure mimics the transition state in enzyme-catalyzed reactions, allowing it to be recognized by specific glycosidases and used to build glycosidic bonds.

Highly efficient substrates for enzymatic transglycosylation: Glycosyloxazolines are more reactive and specific than traditional glycosylation donors. Under the catalysis of endoglycosidase (such as Endo-A, Endo-M, etc.) or its engineered mutants, the efficient and regioselective transfer of sugar chains to specific amino groups (such as asparagine-linked GlcNAc) or specific glycosyl acceptor molecules can be achieved, avoiding the cumbersome protection and deprotection steps in traditional chemical glycosylation.

Modular synthesis potential: This molecule can be used as a core module to construct uniform sugar chains or glycoconjugates with complex structures, providing the possibility to obtain high-purity specific glycoglycoproteins.

Main applications and value

Chemoenzymatic synthesis of homogeneous glycoproteins

Using glycosyloxazoline as a donor, the pre-designed complete oligosaccharide chain can be efficiently transferred to the specific glycosylation site of the target protein or peptide (such as a protein with GlcNAc) in one step through an endoglycosidase-catalyzed transglycosylation reaction. This strategy bypasses the complexity of the intracellular glycosylation process and enables the large-scale preparation of uniform glycoproteins with well-defined structures and specific glycoforms for functional research, structural elucidation, and drug development.

Key intermediates for the development of carbohydrate vaccines and carbohydrate drugs

Many pathogen surface antigens and tumor-associated antigens are glycoproteins or glycolipids in nature. Glycosyloxazoline-based synthesis methods can accurately copy these key sugar epitopes and couple them to carrier proteins for the development of a new generation of glycoconjugate vaccines. In addition, this strategy also provides a powerful in vitro synthetic tool for the production of consistent and optimized glycoforms (such as afucosylation to enhance ADCC effects) required for the production of therapeutic monoclonal antibodies.

Carbohydrase mechanism research and tool development

Glycosyloxazoline is an ideal probe molecule for studying the catalytic mechanism, substrate specificity and kinetic properties of key glycobiological enzymes such as endoglycosidases and glycosyltransferases. Enzymatic synthesis platforms developed based on such molecules have been widely used in the preparation of various complex oligosaccharides, glycopeptides and glycoproteins.

Diagnostic Tools and Biomarker Research

Abnormal changes in specific glycoform structures are closely related to various disease states such as cancer, inflammation, and neurodegenerative diseases. By synthesizing standard glycoproteins or glycopeptides carrying specific abnormal glycoforms, they can be used as standards or capture reagents for the development of highly sensitive diagnostic detection methods to facilitate the discovery and verification of disease biomarkers.

Conclusion

CBNGO00044, as a carefully designed Glycan Oxazoline tool molecule, represents the evolution of glycoprotein synthesis technology from biomimetic to precise construction. It not only provides a sharp tool for in-depth exploration of the mysteries of glycosylation, the language of life, but also shows great potential and value in promoting the transformation of next-generation biotherapeutics based on glycosylation (such as glycoengineered antibodies and glycovaccination) from the laboratory to the clinic. It is an important bridge between basic glycosylation and the development of innovative glycomedicines.

The above information is provided by the editor of KASONS and is for scientific research only.